Familial lipoprotein lipase deficiency caused by known (G188E) and novel (W394X) LPL gene mutations

Ann Clin Biochem 2008;45:102-105
doi:10.1258/acb.2007.007080
© 2008 Association for Clinical Biochemistry

This Article
Right arrow
Figures Only
Right arrow
Full Text
Right arrow

Full Text (PDF)

Right arrow
Alert me when this article is cited
Right arrow
Alert me if a correction is posted
Services
Right arrow
Email this article to a friend
Right arrow

Similar articles in this journal

Right arrow
Similar articles in PubMed
Right arrow
Alert me to new issues of the journal
Right arrow
Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow
Articles by Hooper, A J
Right arrow
Articles by Burnett, J R
Right arrow Search for Related Content
PubMed
Right arrow
PubMed Citation
Social Bookmarking

What’s this?

Case Report


A J Hooper 1,
G M Crawford 2,
J M Brisbane 2,
K Robertson 1,
G F Watts 3,
F M van Bockxmeer 1 2 and
J R Burnett 1 3 


1 Department of Core Clinical Pathology and Biochemistry, PathWest Laboratory Medicine WA;
2 School of Surgery and Pathology;
3 School of Medicine and Pharmacology, University of Western Australia, Royal Perth Hospital, GPO Box X2213, Perth, WA 6847, Australia


Corresponding author: Dr John R Burnett, Department of Core Clinical Pathology and Biochemistry, PathWest Laboratory Medicine WA, Royal Perth Hospital, GPO Box X2213, Perth, WA 6847, Australia. Email: john.burnett{at}health.wa.gov.au

Lipoprotein lipase (LPL) is the key enzyme in the catabolism of triglyceride-rich lipoproteins in the circulation. Familial LPL deficiency is characterized by hypertriglyceridaemia and absence of LPL activity. We report a case of LPL deficiency in a 43-year-old woman, who initially presented in childhood with chylomicronaemia syndrome. At that time, her plasma triglyceride concentration was ~30 mmol/L and post-heparin lipolytic activity was very low. In addition to having the known missense mutation LPL G188E, the patient was also found to have a novel nonsense mutation in exon 8, namely LPL W394X. The novel substitution in exon 8 (c.1262G > A) predicts a truncated protein product of 393 amino acids that lacks the carboxyl-terminal 12% of the mature LPL. Trp394 is part of a cluster of exposed tryptophan residues in the carboxyl-terminal domain of LPL important for binding lipid substrate. Of 11 members from her three-generation family, three were heterozygotes for G188E (mean plasma triglyceride, 3.5 ± 2.0 mmol/L), whereas six were heterozygotes for W394X (triglyceride, 4.3 ± 1.8 mmol/L). In summary, we describe a case of familial LPL deficiency caused by compound heterozygosity for known (G188E) and novel (W394X) LPL genemutations.


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What’s this?